Kevin Cole

Kevin obtained a Ph.D. in organic chemistry from the University of Minnesota and then performed postdoctoral studies in large natural product total synthesis at The Scripps Research Institute in San Diego. He joined the process chemistry group at Lilly in 2007 and contributed to route design and clinical CT supply for numerous small molecule assets. Kevin was a member of the continuous processing group for many years and transferred several flow processes to manufacturing. He began working on bioconjugates in 2022 is currently leading Lilly's Bioproduct R&D bioconjugate team.